CompletedNot Applicable

Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients

France811 participantsStarted 2020-06-22

Plain-language summary

To limit the pandemic Covid-19 infection, the French government imposed a closure of all Intensive Care Unit (ICU). The family's visitations are prohibited during active Covid -19 pandemic in 2020 and in 2021. This restrictive visit policy could result in an increase in symptoms of anxiety, depression or post-traumatic stress disorder for relatives of ICU patients. The aim of this study is to compare symptoms of anxiety, depression or post-traumatic stress for relatives of ICU patients during Covid period with those during no Covid period (2020 and 2021) with those no Covid period (2022)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Relative of patient who was admitted in ICU and treated with invasive mechanical ventilation administration during 24hours at least. Exclusion Criteria: * Relative who declines the enrollment

What they're measuring

Anxiety

Timeframe: Between 3 and 6 months

Depression

Timeframe: Between 3 and 6 months

Trial details

NCT IDNCT04430049

SponsorUniversity Hospital, Clermont-Ferrand

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-11-09

View on ClinicalTrials.gov More Covid-19 trials